Avenue therapeutics to present baer-101 preclinical data at american society for experimental neurotherapeutics (asent) 2024 annual meeting

Baer-101 demonstrated full suppression of seizure activity in synapcell's gaers model of absence epilepsy, a proven indicator of efficacy in anti-seizure drug development with high predictability of response in humans

ATXI Ratings Summary

ATXI Quant Ranking